Catheter Precision VTAK
NYSE VTAK
$0.17 -0.02 (-10.83%)
As of: Sep 9, 2026 · 3:59 PM EDT

Catheter Precision (VTAK) Income from Non-Controlling Interests (2025 - 2026)

Catheter Precision's (VTAK) quarterly Income from Non-Controlling Interests came in at -$11000.0 in Q2 2026, up 96.85% year-over-year from -$5588.1 in Q2 2025, and down 22.22% quarter-over-quarter from -$9000.0 in Q1 2026.

Analysis

Catheter Precision (VTAK) Income from Non-Controlling Interests (2025 - 2026) Analysis & Trends

Catheter Precision (VTAK) has reported Income from Non-Controlling Interests for 2 consecutive years, with -$11000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Income from Non-Controlling Interests rose 96.85% year-over-year to -$11000.0 in Q2 2026; TTM through Jun 2026 was -$183000.0, a 47.56% increase from a year earlier, with the FY2025 full-year figure at -$512000.0, changed N/A from the prior year.
  • Income from Non-Controlling Interests was -$11000.0 for Q2 2026 at Catheter Precision, down from -$9000.0 in the prior quarter.
  • Over five years, Income from Non-Controlling Interests peaked at -$9000.0 in Q1 2026 and troughed at -$349000.0 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 6.60 Mn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 9.00 Mn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn -
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn -2.00 Mn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn -500,000.00
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn -
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 900,000.00
10 Catheter Precision 480,427.59 -1.36 Mn 98,000.00 -11,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11,000.00
Mar 31, 2026 -9,000.00
Dec 31, 2025 -70,000.00
Sep 30, 2025 -93,000.00
Jun 30, 2025 -349,000.00